JERUSALEM - Teva Pharmaceutical Industries , which this week revealed plans to buy Allergan's generics drugs business in a $40.5 billion deal, said on Thursday sales of its branded multiple sclerosis drug Copaxone rose 12 percent in the second quarter even though it faces new competition.
- Health insurer Cigna Corp, which agreed to be bought by Anthem Inc for $47 billion this month, reported a 2.6 percent rise in quarterly profit as it added more members in its commercial and government businesses.
RIO DE JANEIRO - Athletes risk serious illness from dangerously high levels of viruses and bacteria in sewage-contaminated waters at the swimming and boating venues being prepared for the 2016 Olympic Games in Rio de Janeiro, the Associated Press reported on Thursday.
LONDON - Drugmaker GlaxoSmithKline, which was fined a record 3 billion yuan ($483 million) for corruption in China last year and is examining possible staff misconduct elsewhere, faces new allegations of bribery in Romania.
NEW YORK - When Matt and Jen Osmun opened their vape shop in Bethel, Connecticut, last December, they didn't expect to get a boost from the local medical marijuana outlet.
- Romanian anti-corruption prosecutors have conducted a series of searches at drug companies, hospitals and clinics this week to investigate suspected bribes paid to doctors for prescribing cancer drugs.
WASHINGTON - Opponents of President Barack Obama's soon-to-be-implemented policy to cut carbon emissions from power plants are planning to use an unlikely and potentially potent weapon against him: the recent U.S. Supreme Court decision that saved Obamacare.
LONDON - The world's first malaria vaccine, which won a green light last week from European drugs regulators, will be rolled out gradually in Africa, its maker said on Wednesday.
(Reuters Health) - Being connected to friends, family and social groups may offer some protection against suicide, suggests a new U.S. study.
(Reuters Health) - As dietary sodium levels go up over time, so does the risk for high blood pressure, suggests a new study that followed more than 4,000 adults in Japan for four years.